169 related articles for article (PubMed ID: 15650222)
1. Vaccination with an inactivated virulent feline immunodeficiency virus engineered to express high levels of Env.
Hosie MJ; Klein D; Binley JM; Dunsford TH; Jarrett O; Neil JC; Knapp E; Giannecchini S; Matteucci D; Bendinelli M; Hoxie JA; Willett BJ
J Virol; 2005 Feb; 79(3):1954-7. PubMed ID: 15650222
[TBL] [Abstract][Full Text] [Related]
2. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.
Flynn JN; Beatty JA; Cannon CA; Stephens EB; Hosie MJ; Neil JC; Jarrett O
AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1107-13. PubMed ID: 8554908
[TBL] [Abstract][Full Text] [Related]
3. FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection.
Lutz H; Hofmann-Lehmann R; Bauer-Pham K; Holznagel E; Tozzini F; Bendinelli M; Reubel G; Aubert A; Davis D; Cox D
Vet Immunol Immunopathol; 1995 May; 46(1-2):103-13. PubMed ID: 7618250
[TBL] [Abstract][Full Text] [Related]
4. Enhancement after feline immunodeficiency virus vaccination.
Hosie MJ; Osborne R; Reid G; Neil JC; Jarrett O
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):191-7. PubMed ID: 1337397
[TBL] [Abstract][Full Text] [Related]
5. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
[TBL] [Abstract][Full Text] [Related]
6. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of live feline immunodeficiency virus vaccines with modified antigenic properties.
Broche-Pierre S; Richardson J; Moraillon A; Sonigo P
J Gen Virol; 2005 Sep; 86(Pt 9):2495-2506. PubMed ID: 16099908
[TBL] [Abstract][Full Text] [Related]
8. SIV and FIV vaccine studies at UC Davis: 1991 update.
Gardner M; Yamamoto J; Marthas M; Miller C; Jennings M; Rosenthal A; Luciw P; Planelles V; Yilma T; Giavedoni L
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1495-8. PubMed ID: 1334682
[No Abstract] [Full Text] [Related]
9. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
[TBL] [Abstract][Full Text] [Related]
10. DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus.
Cuisinier AM; Mallet V; Meyer A; Caldora C; Aubert A
Vaccine; 1997 Jul; 15(10):1085-94. PubMed ID: 9269051
[TBL] [Abstract][Full Text] [Related]
11. Experimental vaccine protection against feline immunodeficiency virus.
Yamamoto JK; Okuda T; Ackley CD; Louie H; Pembroke E; Zochlinski H; Munn RJ; Gardner MB
AIDS Res Hum Retroviruses; 1991 Nov; 7(11):911-22. PubMed ID: 1662057
[TBL] [Abstract][Full Text] [Related]
12. Vaccination of cats with recombinant envelope glycoprotein of feline immunodeficiency virus: decreased viral load after challenge infection.
Lutz H; Hofmann-Lehmann R; Leutenegger C; Allenspach K; Cuisinier AM; Cronier J; Duquesne V; Aubert A
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):431-3. PubMed ID: 8882327
[No Abstract] [Full Text] [Related]
13. Evaluation of subunit vaccines against feline immunodeficiency virus infection.
Verschoor EJ; Willemse MJ; Stam JG; van Vliet AL; Pouwels H; Chalmers SK; Horzinek MC; Sondermeijer PJ; Hesselink W; de Ronde A
Vaccine; 1996 Mar; 14(4):285-9. PubMed ID: 8744554
[TBL] [Abstract][Full Text] [Related]
14. Lack of protection against feline immunodeficiency virus infection among domestic cats in New Zealand vaccinated with the Fel-O-Vax® FIV vaccine.
Stickney A; Ghosh S; Cave NJ; Dunowska M
Vet Microbiol; 2020 Nov; 250():108865. PubMed ID: 33045631
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of feline monocyte-derived dendritic cells loaded with internally inactivated virus as a vaccine against feline immunodeficiency virus.
Freer G; Matteucci D; Mazzetti P; Tarabella F; Catalucci V; Ricci E; Merico A; Bozzacco L; Pistello M; Bendinelli M
Clin Vaccine Immunol; 2008 Mar; 15(3):452-9. PubMed ID: 18216184
[TBL] [Abstract][Full Text] [Related]
16. Limited efficacy of an inactivated feline immunodeficiency virus vaccine.
Dunham SP; Bruce J; MacKay S; Golder M; Jarrett O; Neil JC
Vet Rec; 2006 Apr; 158(16):561-2. PubMed ID: 16632531
[No Abstract] [Full Text] [Related]
17. Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines.
Hosie MJ; Osborne R; Yamamoto JK; Neil JC; Jarrett O
J Virol; 1995 Feb; 69(2):1253-5. PubMed ID: 7815500
[TBL] [Abstract][Full Text] [Related]
18. Lessons from the cat: development of vaccines against lentiviruses.
Dunham SP
Vet Immunol Immunopathol; 2006 Jul; 112(1-2):67-77. PubMed ID: 16678276
[TBL] [Abstract][Full Text] [Related]
19. Immunization trial of cats with a replication-defective adenovirus type 5 expressing the ENV gene of feline immunodeficiency virus.
Gonin P; Fournier A; Oualikene W; Moraillon A; Eloit M
Vet Microbiol; 1995 Aug; 45(4):393-401. PubMed ID: 7483252
[TBL] [Abstract][Full Text] [Related]
20. A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity.
Lombardi S; Garzelli C; Pistello M; Massi C; Matteucci D; Baldinotti F; Cammarota G; da Prato L; Bandecchi P; Tozzini F
J Virol; 1994 Dec; 68(12):8374-9. PubMed ID: 7966629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
